Rebekah W Moehring
Overview
    Explore the profile of Rebekah W Moehring including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              81
            
            
              Citations
              985
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Kim J, Margolin E, Barquin D, Moehring R, Antonelli J, Lipkin M, et al.
  
  
    J Endourol
    . 2025 Feb;
    
    PMID: 39925120
  
  
          Urine cultures are routinely used to inform preoperative antibiotic choice and duration prior to endourologic surgery. The presence of mixed flora in preoperative urine cultures holds unclear clinical significance. This...
      
2.
        
    
    Turner N, Grambow S, Polage C, Kuhar D, Kutty P, Moehring R, et al.
  
  
    Clin Infect Dis
    . 2025 Jan;
    
    PMID: 39828613
  
  
          Importance: The natural history of C. difficile progression in nucleic acid amplification test (NAAT) positive, toxin enzyme immunoassay-negative patients remains poorly described. Better understanding risk for subsequent disease may improve...
      
3.
        
    
    Fabre V, Hsu Y, Carroll K, Salinas A, Gadala A, Bower C, et al.
  
  
    JAMA Netw Open
    . 2025 Jan;
          8(1):e2454738.
    
    PMID: 39813030
  
  
          Importance: Blood culture (BC) use benchmarks in US hospitals have not been defined. Objective: To characterize BC use in adult intensive care units (ICUs) and wards in US hospitals. Design,...
      
4.
        
    
    Fabre V, Cosgrove S, Milstone A, Salinas A, Degnan K, Gettler E, et al.
  
  
    Infect Control Hosp Epidemiol
    . 2024 Dec;
          :1-9.
    
    PMID: 39703070
  
  
          Objective: To understand healthcare workers' (HCWs) beliefs and practices toward blood culture (BCx) use. Design: Cross-sectional electronic survey and semi-structured interviews. Setting: Academic hospitals in the United States. Participants: HCWs...
      
5.
        
    
    Kim T, Moehring R, Turner N, Ashley E, Crane L, Padgette P, et al.
  
  
    Infect Control Hosp Epidemiol
    . 2024 Dec;
          1-7.
    
    PMID: 39624024
  
  
          Background: Carbapenem-resistant  (CRE) are an urgent threat to healthcare, but the epidemiology of these antimicrobial-resistant organisms may be evolving in some settings since the COVID-19 pandemic. An updated analysis of...
      
6.
        
    
    Kwon J, Advani S, Branch-Elliman W, Braun B, Cheng V, Chiotos K, et al.
  
  
    Infect Control Hosp Epidemiol
    . 2024 Oct;
          1-18.
    
    PMID: 39448369
  
  
          No abstract available.
      
7.
        
    
    Deri C, Moehring R, Turner N, Spivey J, Advani S, Wrenn R, et al.
  
  
    Antimicrob Steward Healthc Epidemiol
    . 2024 Oct;
          4(1):e158.
    
    PMID: 39371441
  
  
          Objective: We aimed to determine whether automated identification of antibiotic targeting suspected urinary tract infection (UTI) shortened the time to antimicrobial stewardship (AS) intervention. Design: Retrospective before-and-after study. Setting: Tertiary...
      
8.
        
    
    Perez R, Hayes J, Winters A, Wrenn R, Moehring R
  
  
    Antimicrob Steward Healthc Epidemiol
    . 2024 Apr;
          4(1):e51.
    
    PMID: 38655017
  
  
          We performed a knowledge, attitudes, and practice (KAP) survey of bedside nurses to evaluate perceptions of antimicrobial use and aid in the design of nursing-based antimicrobial stewardship interventions. The survey...
      
9.
        
    
    Perez R, Yarrington M, Deri C, Smith M, Hayes J, Wrenn R, et al.
  
  
    Open Forum Infect Dis
    . 2024 Apr;
          11(4):ofae141.
    
    PMID: 38577030
  
  
          Background: Advanced practice providers (APPs) have taken on increasing responsibilities as primary team members in acute care hospitals, but the impact of this practice shift on antimicrobial prescribing and infectious...
      
10.
        
    
    Wrenn R, Slaton C, Diez Sr T, Turner N, Yarrington M, Anderson D, et al.
  
  
    Infect Control Hosp Epidemiol
    . 2024 Feb;
          45(6):733-739.
    
    PMID: 38347810
  
  
          Objective: To determine whether removal of default duration, embedded in electronic prescription (e-script), influenced antibiotic days of therapy. Design: Interrupted time-series analysis. Setting: The study was conducted across 2 community...